Cargando…

Glucocerebrosidase mRNA is Diminished in Brain of Lewy Body Diseases and Changes with Disease Progression in Blood

Parkinson disease (PD) and dementia with Lewy bodies (DLB) are Lewy body diseases characterized by abnormal alpha-synuclein deposits and overlapping pathological features in the brain. Several studies have shown that glucocerebrosidase (GBA) deficiency is involved in the development of LB diseases....

Descripción completa

Detalles Bibliográficos
Autores principales:	Perez-Roca, Laia, Adame-Castillo, Cristina, Campdelacreu, Jaume, Ispierto, Lourdes, Vilas, Dolores, Rene, Ramon, Alvarez, Ramiro, Gascon-Bayarri, Jordi, Serrano-Munoz, Maria A., Ariza, Aurelio, Beyer, Katrin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JKL International LLC 2018
Materias:	Orginal Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963343/ https://www.ncbi.nlm.nih.gov/pubmed/29896411 http://dx.doi.org/10.14336/AD.2017.0505

Ejemplares similares

Expression Levels of an Alpha-Synuclein Transcript in Blood May Distinguish between Early Dementia with Lewy Bodies and Parkinson’s Disease
por: Marsal-García, Laura, et al.
Publicado: (2021)

Platelet miRNA Biosignature Discriminates between Dementia with Lewy Bodies and Alzheimer’s Disease
por: Gámez-Valero, Ana, et al.
Publicado: (2021)

Exploratory study on microRNA profiles from plasma-derived extracellular vesicles in Alzheimer’s disease and dementia with Lewy bodies
por: Gámez-Valero, Ana, et al.
Publicado: (2019)

Molecular Pathology of Lewy Body Diseases
por: Beyer, Katrin, et al.
Publicado: (2009)

Severe Hyperammonemia in Late-Onset Ornithine Transcarbamylase Deficiency Triggered by Steroid Administration
por: Gascon-Bayarri, Jordi, et al.
Publicado: (2015)

Glucocerebrosidase Mutations alter the endoplasmic reticulum and lysosomes in Lewy body disease
por: Kurzawa-Akanbi, Marzena, et al.
Publicado: (2012)

Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies
por: Chiasserini, Davide, et al.
Publicado: (2015)

A severe neurodegenerative disease with Lewy bodies and a mutation in the glucocerebrosidase gene
por: Sipilä, Jussi O. T., et al.
Publicado: (2023)

Comprehensive proteomic profiling of plasma-derived Extracellular Vesicles from dementia with Lewy Bodies patients
por: Gámez-Valero, Ana, et al.
Publicado: (2019)

T1-weighted MRI-driven Brain Age Estimation in Alzheimer’s Disease and Parkinson’s Disease
por: Beheshti, Iman, et al.
Publicado: (2019)

Clinical Profile of Chinese Long-Term Parkinson’s Disease Survivors With 10 Years of Disease Duration and Beyond
por: Sun, Qian, et al.
Publicado: (2018)

Emotional Lability at Disease Onset Is an Independent Prognostic Factor of Faster Disease Progression in Amyotrophic Lateral Sclerosis
por: Barć, Krzysztof, et al.
Publicado: (2020)

Hydroxyurea Facilitates Manifestation of Disease Relevant Phenotypes in Patients-Derived IPSCs-Based Modeling of Late-Onset Parkinson’s Disease
por: Tan, Yuan, et al.
Publicado: (2019)

Disease Progression-Dependent Expression of CD200R1 and CX3CR1 in Mouse Models of Parkinson’s Disease
por: Wang, Le, et al.
Publicado: (2020)

Frailty Predicts an Increased Risk of End-Stage Renal Disease with Risk Competition by Mortality among 165,461 Diabetic Kidney Disease Patients
por: Chao, Chia-Ter, et al.
Publicado: (2019)

Frailty in Older Adults with Cardiovascular Disease: Cause, Effect or Both?
por: Kleipool, Emma EF., et al.
Publicado: (2018)

Olfactory Dysfunction and Its Relationship with Clinical Symptoms of Alzheimer Disease
por: Yu, Qiujin, et al.
Publicado: (2018)

Immune Characteristics of Patients with Coronavirus Disease 2019 (COVID-19)
por: Dong, Xiaotian, et al.
Publicado: (2020)

Alteration of Metabolic Profile and Potential Biomarkers in the Plasma of Alzheimer’s Disease
por: Shao, Yaping, et al.
Publicado: (2020)

REST rs3796529 Genotype and Rate of Functional Deterioration in Alzheimer’s Disease
por: Huang, Poyin, et al.
Publicado: (2019)

The Synergy of Aging and LPS Exposure in a Mouse Model of Parkinson’s Disease
por: Zhao, Yong-Fei, et al.
Publicado: (2018)

Mitochondrial Creatine Kinase is Decreased in the Serum of Idiopathic Parkinson’s Disease Patients
por: Xu, Jinghui, et al.
Publicado: (2019)

Gait Characteristics and Brain Activity in Parkinson’s Disease with Concomitant Postural Abnormalities
por: Yao, Meng-sha, et al.
Publicado: (2020)

Targeting Mitochondrial Network Disorganization is Protective in C. elegans Models of Huntington’s Disease
por: Machiela, Emily, et al.
Publicado: (2021)

Chronic Kidney Disease Is Linked to Carotid Nodular Calcification, An Unstable Plaque Not Correlated to Inflammation
por: Cardellini, Marina, et al.
Publicado: (2019)

The Metabolic Activity of Caudate and Prefrontal Cortex Negatively Correlates with the Severity of Idiopathic Parkinson’s Disease
por: Chu, Jun-Sheng, et al.
Publicado: (2019)

Aging Influences Hepatic Microvascular Biology and Liver Fibrosis in Advanced Chronic Liver Disease
por: Maeso-Díaz, Raquel, et al.
Publicado: (2019)

Entorhinal Cortex Atrophy in Early, Drug-naive Parkinson’s Disease with Mild Cognitive Impairment
por: Jia, Xiuqin, et al.
Publicado: (2019)

Outcomes in Endovascular Therapy for Basilar Artery Occlusion: Intracranial Atherosclerotic Disease vs. Embolism
por: Wu, Longfei, et al.
Publicado: (2021)

Extracellular GAPDH Promotes Alzheimer Disease Progression by Enhancing Amyloid-β Aggregation and Cytotoxicity
por: Lazarev, Vladimir F, et al.
Publicado: (2021)

Muscle Fatigue Does Not Change the Effects on Lower Limbs Strength Caused by Aging and Parkinson’s Disease
por: Alota Ignacio Pereira, Vinicius, et al.
Publicado: (2018)

Total Burden of Cerebral Small Vessel Disease in Recurrent ICH versus First-ever ICH
por: Xu, Mangmang, et al.
Publicado: (2019)

Genetic Interaction of APOE and FGF1 is Associated with Memory Impairment and Hippocampal Atrophy in Alzheimer’s Disease
por: Chang, Ya-Ting, et al.
Publicado: (2019)

Six Visual Rating Scales as A Biomarker for Monitoring Atrophied Brain Volume in Parkinson’s Disease
por: Lin, Yu, et al.
Publicado: (2020)

Rationale and Methodology of The PopulatION HEalth and Eye Disease PRofile in Elderly Singaporeans Study [PIONEER]
por: Gupta, Preeti, et al.
Publicado: (2020)

Clinical and Genetic Profiles in Chinese Patients with Huntington’s Disease: A Ten-year Multicenter Study in China
por: Li, Hong-Lei, et al.
Publicado: (2019)

Nilotinib Improves Bioenergetic Profiling in Brain Astroglia in the 3xTg Mouse Model of Alzheimer’s Disease
por: Adlimoghaddam, Aida, et al.
Publicado: (2021)

Fucoidan Protects Dopaminergic Neurons by Enhancing the Mitochondrial Function in a Rotenone-induced Rat Model of Parkinson’s Disease
por: Zhang, Li, et al.
Publicado: (2018)

Characterization of Alzheimer’s Disease Using Ultra-high b-values Apparent Diffusion Coefficient and Diffusion Kurtosis Imaging
por: Xue, Yingnan, et al.
Publicado: (2019)

Fibrinogen is an Independent Risk Factor for White Matter Hyperintensities in CADASIL but not in Sporadic Cerebral Small Vessel Disease Patients
por: Guo, Xingfang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t66il6cjqjsome486itgnait77